Dynamic Biomarkers for Deep Immune Phenotyping in Autoimmune Disease
Now On Demand | Hosted by Oxford Global
Autoimmune diseases present with a wide range of clinical symptoms, severity, and therapeutic response, complicating the diagnosis and treatment of patients. Small molecule biomarkers read out dynamic changes that occur with immune system activation, dysregulation, and response to drug exposure.
In this webinar, we discuss how high throughput mass spectrometry-based methods can be applied to broadly assay thousands of metabolites and lipids per sample at a time, to read out early and subtle changes in immune cell populations, their activation and function, and dynamic response in the setting of autoimmune disease and treatment.
Watch the webinar to learn:
Why discovery of dynamic small molecule biomarkers in the setting of autoimmunity can drive greater understanding of disease mechanisms and subtypes, patient response, and drug safety
How emerging technologies are now enabling rapid measure of dynamic small molecule biomarkers at population level scale
How integration of small molecule biomarkers with other dynamic readouts, including cytokine measures, can inform development of safer, more efficacious treatments that target the underlying pathways of autoimmune diseases